Clinical Research Informer

ALS Association partners with myTomorrows to improve clinical trial accessibility

Pharma Times

MARCH 19, 2024

The fatal motor neurone disease currently does not have a cure available to treat patients

Clinical Trials

Clinical Trials Clinical Trials Trials

KCL researchers develop pipeline to create customisable cell culture device creations

Pharma Times

MARCH 19, 2024

The SOL3D pipeline addresses research challenges in relation to equipment, expertise and cost

Research

Research Development

AZ/Merck’s Lynparza approved by SMC to treat advanced prostate cancer in Scotland

Pharma Times

MARCH 18, 2024

Up to 20% of prostate cancer cases are classified as castration-resistant

Medicine

Birmingham’s VR-assisted training centre for excellence to support future vaccine makers

Pharma Times

MARCH 18, 2024

The centre will deliver free training, outreach materials and programmes

Vaccination

Vaccination Vaccine Life Science Manufacturing

US study reveals age-related skin changes could contribute to melanoma metastases

Pharma Times

MARCH 13, 2024

Around 200,000 people in the US are expected to be diagnosed with the skin cancer this year

AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland

Pharma Times

MARCH 13, 2024

The progressive neurological disorder affects approximately 12,400 people in Scotland

Medicine

ICR awarded $25m by Cancer Grand Challenges to research solid tumours in children

Pharma Times

MARCH 12, 2024

Globally, cancer is currently the most leading cause of death due to disease among children

Research

NHS campaign urges over 900,000 young adults to catch up on missed MMR vaccine

Pharma Times

MARCH 12, 2024

Between October 2023 and March 2024, the UKHSA said that 733 cases of measles were reported in England

Vaccination

Vaccination Vaccine

New brain cancer proton beam therapy clinical trial launched in UK

Pharma Times

FEBRUARY 22, 2024

The trial is recruiting patients in Leeds, Manchester, Oxford, London, Cambridge and Kent

Clinical Trials

Clinical Trials Clinical Trials Trials Research

NHS launches new campaign to help patients get treatment from pharmacies

Pharma Times

FEBRUARY 22, 2024

Pharmacy First will enable patients to receive treatment for seven common conditions

Pharmacy

Elicio’s vaccine shows promise as potential cancer treatment in phase 1 trial

Pharma Times

FEBRUARY 21, 2024

Results showed robust responses in patients with pancreatic and colorectal cancer

Vaccination

Vaccination Vaccine Trials

Researchers launch global iSPY network to research Strep A infections

Pharma Times

FEBRUARY 21, 2024

A streptococcal bacterial infections are estimated to affect around 50 million people worldwide

Research

NHS launches BRCA testing programme for people of Jewish descent

Pharma Times

FEBRUARY 2, 2024

Individuals with Jewish ancestry are six times more likely to carry a genetic fault

Genetics

Genetics Gene

Study reveals SARS-CoV-2 can infect dopamine neurons causing senescence

Pharma Times

FEBRUARY 2, 2024

Dopamine neuron senescence is a hallmark of Parkinson’s disease

Medicine

Babies born early have an increased risk of developmental disorders

Pharma Times

DECEMBER 12, 2023

Around 240 million children worldwide are living with these types of disorders - News - PharmaTimes

New study finds heathy cells ‘push’ cancer cells to resist treatment

Pharma Times

DECEMBER 12, 2023

Slow-growing cancer cells become more resistant to chemotherapy treatment - News - PharmaTimes

NHS rolls out online GP registration to over 2,000 practices

Pharma Times

DECEMBER 11, 2023

Around 2,100 GP surgeries had enrolled into the digital service by the end of November - News - PharmaTimes

UKHSA urges individuals from ethnic minority groups to get vaccinated

Pharma Times

DECEMBER 11, 2023

New data highlights the inequalities in emergency hospital rates and vaccinations - News - PharmaTimes

Vaccination

Vaccination Vaccine

PREDICTOM trial backed by €21m for early Alzheimer’s detection

Pharma Times

NOVEMBER 22, 2023

The trial will use an AI screening platform to identify those most at risk of dementia - News - PharmaTimes

Trials

Thousands of men to participate in UK trial for prostate cancer

Pharma Times

NOVEMBER 22, 2023

Prostate cancer is responsible for 12,000 deaths every year in the UK - News - PharmaTimes

Trials

Two charities co-fund £5.5m childhood cancer research programme

Pharma Times

NOVEMBER 21, 2023

SMPaeds2 aims to advance precision medicines for children with relapsed cancer - News - PharmaTimes

Research

Research Medicine

Lab-grown blood vessels could potentially treat strokes and vascular dementia

Pharma Times

NOVEMBER 21, 2023

Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes - News - PharmaTimes

NHS expands COVID-19 research platform for other major diseases

Pharma Times

NOVEMBER 20, 2023

The OpenSAFELY platform will support the discovery of new treatments - News - PharmaTimes

Research

BHF and UKDRI announce first UK centre for vascular dementia research

Pharma Times

NOVEMBER 20, 2023

The centre will help discover new treatments to prevent, halt and cure the condition - News - PharmaTimes

Research

Study reveals diagnosis and treatment inequalities in NHS heart care

Pharma Times

OCTOBER 10, 2023

Researchers focused on four of the most common heart conditions in the UK - News - PharmaTimes

Research

UKRI awards £41m to enhance UK research and innovation

Pharma Times

OCTOBER 10, 2023

The scheme will help ten projects establish research and innovation clusters - News - PharmaTimes

Research

Elligo Health Research expands Study Marketplace with Syneos Health

Pharma Times

OCTOBER 9, 2023

The agreement builds on the companies’s existing partnership - News - PharmaTimes

Research

New University of Bristol study to aid strep A vaccine development

Pharma Times

OCTOBER 9, 2023

The study will offer new insights into the immune system's response to iGAS - News - PharmaTimes

Development

Development Vaccination Vaccine

Intellegens and CPI awarded Innovate UK grant

Pharma Times

AUGUST 30, 2023

Funding will progress the manufacture of oligonucleotide therapeutics alongside machine learning - News - PharmaTimes

Manufacturing

Novartis reveals vital Leqvio data

Pharma Times

AUGUST 30, 2023

The therapy involves treating individuals with atherosclerotic cardiovascular disease - News - PharmaTimes

FDA grants Orphan Drug Designation to Faron’s bexmarilimab in AML

Pharma Times

AUGUST 29, 2023

The ODD will offer clinical development and commercialisation benefits that will strengthen the drug programme - News - PharmaTimes

Drugs

Drugs Clinical Development Development

Takeda and ImmunoGen partner to develop and commercialise Elahere in Japan

Pharma Times

AUGUST 29, 2023

ImmunoGen is expected to receive an upfront payment from Takeda plus additional payment - News - PharmaTimes

Development

Janssen’s Talvey receives positive CHMP opinion

Pharma Times

JULY 24, 2023

The treatment is a monotherapy for treating adult patients with refractory or relapsed multiple myeloma - News - PharmaTimes

EMA positive opinion for ViiV’s cabotegravir

Pharma Times

JULY 24, 2023

The drug is an injectable or tablet specifically developed for HIV prevention among certain individuals - News - PharmaTimes

Development

Development Drugs

CatalYm highlights GDF-15 as main anti-PD-1 resistance factor

Pharma Times

JULY 21, 2023

Data underlines the significance of the company’s anti-GDF-15 antibody candidate, visugromab - News - PharmaTimes

Antibody

Teva UK launches GoResp Digihaler

Pharma Times

JULY 21, 2023

The inhaler supports appropriate individuals presenting with asthma and chronic obstructive pulmonary disease - News - PharmaTimes

Grifols announces phase 3 progress for Albutein

Pharma Times

JULY 20, 2023

Therapy has the potential to decrease mortality rates in patients with decompensated cirrhosis - News - PharmaTimes

UCB announces EMA bimekizumab verdict

Pharma Times

JULY 20, 2023

In two studies the therapy demonstrated improvements when compared with the placebo - News - PharmaTimes

Glaucoma therapy Roclanda launched by Santen

Pharma Times

JULY 19, 2023

By combining both netarsudil and latanoprost treatment, Roclanda reduces intraocular pressure - News - PharmaTimes

Members of the Alliance for Genomic Discovery revealed

Pharma Times

JULY 19, 2023

Illumina and Nashville Biosciences’ have announced AbbVie, Amgen, AstraZeneca, Bayer and Merck as founding members - News - PharmaTimes

Genome

Genome Genomics

genedrive awarded test kit grant

Pharma Times

JUNE 16, 2023

DEVOTE grant will allow acute care patient access and a supporting infrastructure for the company - News - PharmaTimes

Rosemont acquires Lucis Pharma to boost portfolio

Pharma Times

JUNE 16, 2023

Company will gain access to a considerable pipeline of liquid products covering various disease areas - News - PharmaTimes

Production

Vital patent for AlzeCure Alzheimer’s drug

Pharma Times

MAY 22, 2023

ACD856 is the leading candidate therapy on the company’s NeuroRestore platform

Drugs

Eisai makes lecanemab therapy application

Pharma Times

MAY 22, 2023

Treatment involves early Alzheimer’s disease and will be potentially used across Great Britain

Pharma Times

ALS Association partners with myTomorrows to improve clinical trial accessibility

KCL researchers develop pipeline to create customisable cell culture device creations

Trending Sources

AZ/Merck’s Lynparza approved by SMC to treat advanced prostate cancer in Scotland

Birmingham’s VR-assisted training centre for excellence to support future vaccine makers

US study reveals age-related skin changes could contribute to melanoma metastases

AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland

ICR awarded $25m by Cancer Grand Challenges to research solid tumours in children

NHS campaign urges over 900,000 young adults to catch up on missed MMR vaccine

New brain cancer proton beam therapy clinical trial launched in UK

NHS launches new campaign to help patients get treatment from pharmacies

Elicio’s vaccine shows promise as potential cancer treatment in phase 1 trial

Researchers launch global iSPY network to research Strep A infections

NHS launches BRCA testing programme for people of Jewish descent

Study reveals SARS-CoV-2 can infect dopamine neurons causing senescence

Babies born early have an increased risk of developmental disorders

New study finds heathy cells ‘push’ cancer cells to resist treatment

NHS rolls out online GP registration to over 2,000 practices

UKHSA urges individuals from ethnic minority groups to get vaccinated

PREDICTOM trial backed by €21m for early Alzheimer’s detection

Thousands of men to participate in UK trial for prostate cancer

Two charities co-fund £5.5m childhood cancer research programme

Lab-grown blood vessels could potentially treat strokes and vascular dementia

NHS expands COVID-19 research platform for other major diseases

BHF and UKDRI announce first UK centre for vascular dementia research

Study reveals diagnosis and treatment inequalities in NHS heart care

UKRI awards £41m to enhance UK research and innovation

Elligo Health Research expands Study Marketplace with Syneos Health

New University of Bristol study to aid strep A vaccine development

Intellegens and CPI awarded Innovate UK grant

Novartis reveals vital Leqvio data

FDA grants Orphan Drug Designation to Faron’s bexmarilimab in AML

Takeda and ImmunoGen partner to develop and commercialise Elahere in Japan

Janssen’s Talvey receives positive CHMP opinion

EMA positive opinion for ViiV’s cabotegravir

CatalYm highlights GDF-15 as main anti-PD-1 resistance factor

Teva UK launches GoResp Digihaler

Grifols announces phase 3 progress for Albutein

UCB announces EMA bimekizumab verdict

Glaucoma therapy Roclanda launched by Santen

Members of the Alliance for Genomic Discovery revealed

genedrive awarded test kit grant

Rosemont acquires Lucis Pharma to boost portfolio

Vital patent for AlzeCure Alzheimer’s drug

Eisai makes lecanemab therapy application

Stay Connected